4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0000950170-25-038113
Options or other derivatives
- General Counsel and Secretary acquired 750,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Samuel George A. III · General Counsel and Secretary
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-03-10 | Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) | +750,000 | 750,000 | D |
Loading xslF345X05/ownership.xml…